Search Tag: cancer drugs

Executive Health Management

Cancer Drug Costs Need to Drop

2015 08 Aug

In a manifesto, a group of eminent oncologists note how the steep prices of cancer drugs are affecting the care of patients with cancer. They cite data showing that in 2014 all new FDA-approved cancer drugs were priced above $120,000 per year of use. They are calling for a reduction in drug prices.  While the skyrocketing drug prices may be driving... Read more

Executive Health Management

World Cancer Day: European Oncologists Call for Equal Access to Cancer Treatment

2015 04 Feb

 Access to treatment and care is the fundamental right of any patient. In cancer, despite the fast rate of new agent development, there are still astounding inequalities in the availability of and accessibility to cancer medications across Europe, according to the European Society for Medical Oncology, which is leading a European Consortium Study on... Read more

Executive Health Management

Cancer Advance of the Year: New Therapies For Chronic Leukaemia

2015 23 Jan

The American Society of Clinical Oncology (ASCO) has designated four new leukaemia therapies as its cancer Advance of the Year. The announcement was made this week in ASCO’s 10th Annual Report on Progress Against Cancer, which has been published in the Journal of Clinical Oncology.New Treatments, New Hope for CLL PatientsChronic lymphocytic leukaemia... Read more

Pharmacy Management

EMA Backs Record Number of Drugs in 2014

2015 12 Jan

The European Medical Agency (EMA) has shown its support for a record number of orphan medicines in 2014. Out of a total of 82 medicines for human use, 17 are indicated for the treatment of a rare disease. EMA has given positive opinions on 40 new non-orphan drugs, three biosimilars, one drug for paediatric use and 21 generic, hybrid and informed consent... Read more

Pharmacy Management

Drug Combination Delays Progression of Breast Cancer

2014 12 Dec

According to the results of a multi-centre phase II trial presented at the 2014 San Antonio Breast Cancer Symposium, a new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer. The study is based on the work done by Doris Germain of Mt. Sinai Hospital and included 118 post-menopausal... Read more

Endorsed Companies